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Prolonged Shelf Life in Fermented Milk Products 
Investigated by Bioassay-Guided Chemometrics 
 
Introduction 
 
Specific strains of lactic acid bacteria have been 
found to prolong shelf life without significantly 
changing taste or texture of fermented milk 
products if present during fermentation. The 
hypothesis is that the bacteria produce small 
amounts of antimicrobial compounds. The present 
study intents to investigate which antimicrobial 
compound(s) is produced. 
In order to undertake a targeted chemical 
analysis, a yeast-growth bioassay has been 
developed for fermented milk products 
(Reference) or with bioprotective culture (BioP). A 
24-sample metabonomics study including the 
bioassay and NMR spectra has been conducted. 
 
 
Yeast-growth bioassay 
Development of assay  
 
 
The yeast-growth bioassay was developed as a 
microplate assay of 200 mL aqueous extracts of 
the fermented milk products mixed with yeast. 
Aiming for the largest difference between BioP 
and reference samples, the following parameters 
were optimised: 
 
• choice of  contaminant (yeast species) 
• yeast harvested at different phase of growth 
• growth temperature 
• growth medium 
• incubation time 
• initial yeast concentration 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Metabonomics study 
 
Experimental details 
Sample preparation  
 
The aqueous extracts of  fermented milk were 
prepared as follows: 
1.Centrifugation for 2 hours at 20.000g 
2.Aqueous partition transferred to centrifugal filter 
unit (10 kDa, 15 mL). 
3.Centrifugation at 5.000g for 2 hours. 
4.Filtrate was used as aqueous sample. 
 
Bioassay  
 
The optimised bioassay was used in the metabo-
nomics study. All extracts were prepared in tripli-
cate and the bioassay used two separate yeast 
inocula, 6 replicates and biological triplicates. 
 
 
 
NMR spectra  
 
The NMR-spectra were acquired using a 600 MHz 
Bruker Avance III HD spectrometer equipped with 
a cryogenically cooled 5 mm dual-channel probe 
optimized for 13C and 1H. Samples consisted of 
90% extract, 10 % D2O and 10 mM phosphate 
buffer (pH 4.7) and were analyzed at 300 K. 
Proton spectra, at 600.13 MHz, were acquired 
using presaturation and spoil gradients to remove 
water signal, 90º-pulses, a spectral width of 12 
kHz, collecting 512 scans with a length of 32768 
data points with a relaxation delay of 2.0 sec. 
FID's were zero-filled to twice the size and 
exponentially multiplied with a line broadening 
factor of 0.3 Hz before Fourier transform. All 
spectra were manually phase corrected and 
automatically baseline corrected. Two indepen-
dently optimized spectra were acquired for each 
sample. Four samples were removed due to lack 
of concentration. 
 
Principal Component Analysis 
 
The PCA was performed using the Matlab based 
PLS_toolbox v.5.8 combined with in-house 
developed scripts by Nils Nyberg. The data were 
calibrated using the acetoin peak at δ(1H) = 2.13, 
interpolated to a common axis, binned (width of 
0.015 ppm) and bins were adjusted to fit peaks. 
 
 
Results 
Bioassay 
 
The bioassay shows a clear and reproducible 
differentiation between BioP and reference 
samples as exemplified in figure 2. Two BioP 
extracts (red curves) were found to have a 
significantly lower antimicrobial activity probably 
ascribed to the sample preparation or 
inhomogeneities in the samples. 
 
Principal Component Analysis 
 
An overall analysis resulted in the data shown in 
the top row figure 3 and did not point to a 
differentiating factor between BioP and reference 
samples: only a minor concentration difference 
 
among the sugars is identified. This led to a sub-
spectral analysis revealing the most pronounced 
grouping upon evaluation of δ(1H) = 7.8 - 8.6 as 
shown in the middle row figure 3. The major 
difference is attributed to the resonance at 8.35 
ppm. 
Another differentiating spectral region is found 
between 1.3 and 3.1 ppm, where the 
concentrations of acetoin and acetic acid are seen 
to be indicative, however, with a large variation 
between samples (lower row figure 3). 
The BioP samples with low antimicrobial efficacy 
are in all cases seen to group with the other BioP 
samples. 
 
 
Discussion 
 
With the significant differentiation of the samples 
in the bioassay, it is surprisingly small differences 
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Figure 1: Results from microplate-based yeast growth 
assay (Microplate after incubation: Column 2-5 BioP 
samples, 6-9 reference samples, 10 & 11 sterile and growth 
tests). 
which are found in the NMR data. The data does 
not show any new compounds in the BioP 
samples and the differences in concentrations are 
clearly too small to explain the large and 
consistent biological differences. Moreover, the 
BioP samples with low activity (red) group with the 
active BioP samples. As such, it is most likely that 
the antimicrobial activity must be ascribed to a 
compound present at a sub-mM  concentration not 
visible in the proton NMR data. 
 
 
Conclusions and future work 
   
A well functioning yeast-growth bioassay which 
clearly distinguishes between fermented milk 
samples with and without bioprotective lactic acid 
bacteria has been developed. The bioassay was 
successfully applied in the 24-samples 
metabonomics study. The PCA of the NMR 
spectra of the samples revealed only minor 
unspecific concentration differences around δ(1H) 
= 3.5 attributed to sugars. However, sub-spectral 
PCA revealed differences between BioP and 
reference samples regarding acetic acid, acetoin 
and an unidentified compound with δ(1H) = 8.35. 
All compounds showed a slightly higher 
concentration in the BioP samples. These trends, 
however, do not explain the very distinctive 
difference observed in the bioassay and we 
therefore conclude that the antimicrobial 
compound must be present at a sub-mM 
concentration and therefore not visible in the NMR 
data. 
 
With this conclusion, the further analytical work 
will rely primarily on the use of MS-based 
techniques. 
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Figure 3: Score and loading plots from the proton NMR data (Green: BioP samples, Blue: Reference samples, Red: BioP 
samples with low biological activity. First row: All spectral region. Second and third rows: Sub-spectral regions showing some degree 
of separation. The loadings are depicted in colour code on the spectra (blue-yellow-red) and as bins). 
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Figure 2: Growth curves obtained for the samples in the metabonomics study 
(Growth monitored by the developed bioassay as optical density at 630 nm (turbidity) as a function of incubation time. Green: BioP 
samples, Blue: Reference samples, Red: BioP samples with atypical low antimicrobial activity). 
Yeast-growth bioassay and bioassay-guided NMR-based metabonomics 
A yeast-growth bioassay for evaluation of the antimicrobial effect of aqueous extracts of 
fermented milk products has been developed and used in a bioassay-guided NMR-based 
metabonomics study. The bioassay revealed significant differences between the reference 
samples and the samples containing bioprotective culture. The NMR-study, however, revealed 
only minor concentration changes. It is therefore concluded that the antimicrobial compound is 
potent at sub-mM concentrations. Further studies using other analytical techniques are being 
conducted. 
 
